Skúšobnú verziu novej webovej stránky nájdete na beta.sukl.sk. Všetky aktuality, informácie a kompletný obsah sú zatiaľ prioritne dostupné na pôvodnej verzii webu.
en

PRODUCT DETAIL

Linagliptin/Metformin Sandoz 2,5 mg/850 mg

Code 1824F
MA number 18/0384/25-S
Product Form: tbl flm 180 (3x60)x2,5 mg/850 mg (blis.Al/OPA/Al/PVC-multibal.)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
MAH, country: Sandoz Pharmaceuticals d.d., Slovenia
Therapeutic Class: 18 - ANTIDIABETICA (VRÁTANE INZULÍNU)
ATC:
A ALIMENTARY TRACT AND METABOLISM
A10 DRUGS USED IN DIABETES
A10B Blood glucose lowering drugs, excl. insulins
A10BD Combinations of oral blood glucose lowering drugs
A10BD11 Metformin and linagliptin
Shelf life: 24
Container: blister Al/OPA/Al/PVC
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 02.12.2025
Validity: 02.12.2030
PIL: PIL_Linagliptin_Metformin Sandoz_12_2025.pdf  
SPC: SPC_Linagliptin_Metformin Sandoz_12_2025.pdf  
Safety feature Yes
Data update: 11.12.2025
eu-flag.png sk-flag.png